Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» exocrine pancreatic insufficiency
exocrine pancreatic insufficiency
AzurRx BioPharma Is An Ultra-High-Risk IPO
Seeking Alpha
Fri, 08/19/16 - 11:42 am
AzurRx BioPharma
IPOs
exocrine pancreatic insufficiency
Aptalis Pharma Announces FDA Approval of 25,000 Lipase-Unit Strength of ZENPEP(R)
Pipeline Review
Sat, 07/16/11 - 12:07 pm
Aptalis
Zenpep
exocrine pancreatic insufficiency
cystic fibrosis
Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic Insufficiency
Yahoo/PR NewsWire
Sat, 04/16/11 - 01:20 pm
Eli Lilly
liprotamase
exocrine pancreatic insufficiency
Lilly pancreas drug raises questions-US FDA staff
Reuters
Mon, 01/10/11 - 12:10 pm
FDA
Eli Lilly
liprotamase
exocrine pancreatic insufficiency
Eurand Announces Data on Switching Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency From Unapproved PEPs to FDA-Approved ZENPEP(R)
Yahoo/MarketWire
Thu, 06/17/10 - 08:46 am
Aptalis
Zenpep
exocrine pancreatic insufficiency